Pacific Biosciences (PACB) AGM 2026 summary

Opening remarks and agenda

• Meeting opened with a welcome and introduction of board members and key executives in attendance virtually.

• Agenda included addressing proposals from the proxy statement and a Q&A session post-adjournment.

Shareholder proposals

• Four proposals were presented: election of directors, ratification of the independent auditor, advisory vote on executive compensation, and amendment to the 2020 Equity Incentive Plan.

• Board recommended approval of all proposals.

Overview of voting outcomes

• All nominated directors were elected for terms expiring in 2027.

• Ratification of Ernst & Young LLP as independent auditor was approved.

• Advisory approval of executive compensation passed.

• Amendment to the 2020 Equity Incentive Plan, increasing reserved shares by 16 million, was approved.